These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 6127637

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Effectiveness and tolerance of zotepine in a double-blind comparison with perazine in schizophrenic patients].
    Dieterle DM, Müller-Spahn F, Ackenheil M.
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():18-22. PubMed ID: 1683334
    [Abstract] [Full Text] [Related]

  • 4. [Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia].
    Termińska K, Mrowiec W.
    Psychiatr Pol; 1989 Sep; 23(1):24-30. PubMed ID: 2573098
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.
    Levinson I, Levine S.
    Biol Psychiatry; 1995 Aug 01; 38(3):198-200. PubMed ID: 7578667
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial.
    Fleischhacker WW, Barnas C, Stuppäck CH, Unterweger B, Miller C, Hinterhuber H.
    Psychopharmacol Bull; 1989 Aug 01; 25(1):97-100. PubMed ID: 2570438
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A unique case of tardive dystonia induced by short-term therapy with perazin.
    Lohmann T, Ferbert A, Ebel H.
    Pharmacopsychiatry; 1995 Nov 01; 28(6):263-5. PubMed ID: 8773294
    [Abstract] [Full Text] [Related]

  • 15. Behavioral prediction of response to haloperidol: a test dose strategy.
    Neborsky R, Janowsky D, Munson E, Hornbeck C, Depry D.
    J Clin Psychiatry; 1982 Apr 01; 43(4):157-8. PubMed ID: 7068547
    [No Abstract] [Full Text] [Related]

  • 16. Amoxapine as an antipsychotic: comparative study versus haloperidol.
    Chaudhry IB, Husain N, Khan S, Badshah S, Deakin B, Kapur S.
    J Clin Psychopharmacol; 2007 Dec 01; 27(6):575-81. PubMed ID: 18004123
    [Abstract] [Full Text] [Related]

  • 17. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
    Chouinard G, Safadi G, Beauclair L.
    J Clin Psychopharmacol; 1994 Dec 01; 14(6):377-84. PubMed ID: 7884017
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Psychopathometric study of the prognostic significance of psychopathologic findings and premorbid personality for discharge of neuroleptic treated patients with schizophrenic psychoses].
    Möller HJ, von Zerssen D.
    Nervenarzt; 1985 Sep 01; 56(9):498-505. PubMed ID: 2867479
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.